Hans J. Stauss mainly focuses on Cytotoxic T cell, Immunology, Antigen, Molecular biology and T-cell receptor. His Cytotoxic T cell research includes elements of Epitope, T cell and Virology. He combines subjects such as Penetrance and Cancer research with his study of Immunology.
His studies in Antigen integrate themes in fields like Genetic enhancement and Immunotherapy. His study focuses on the intersection of Molecular biology and fields such as Major histocompatibility complex with connections in the field of Peptide. Hans J. Stauss has researched T-cell receptor in several fields, including In vitro, T lymphocyte, CD3, CD8 and Tumor antigen.
His primary areas of study are Immunology, Cytotoxic T cell, Antigen, T-cell receptor and T cell. His Immunology study focuses mostly on Immunotherapy, Immune system, Adoptive cell transfer, Antigen-presenting cell and Leukemia. His biological study spans a wide range of topics, including Molecular biology, Cancer research, CD8 and Major histocompatibility complex.
His Antigen research is multidisciplinary, relying on both Gene, Tumor antigen and Wilms' tumor. The concepts of his T-cell receptor study are interwoven with issues in Gene transfer, CD3, Genetic enhancement, Cell biology and Chimeric antigen receptor. His Epitope research incorporates themes from Immunogenicity and Virology.
Hans J. Stauss focuses on Immunology, T-cell receptor, Cancer research, Immune system and T cell. His Immunology study combines topics in areas such as Cytotoxic T cell and Penetrance. His T-cell receptor research incorporates elements of Avidity, Antigen, Genetic enhancement, Cell biology and Chimeric antigen receptor.
Hans J. Stauss works mostly in the field of Antigen, limiting it down to concerns involving Antibody and, occasionally, Lytic cycle. His Cancer research study integrates concerns from other disciplines, such as Downregulation and upregulation, Stem cell, Cell therapy and Immunotherapy. His T cell research includes themes of Renal transplant and Immune status.
His primary scientific interests are in Immunology, T cell, Cell biology, Primary immunodeficiency and Common variable immunodeficiency. His work carried out in the field of Immunology brings together such families of science as Transplantation and Risk factor. His research integrates issues of Immune status, CD8 and Cancer immunotherapy in his study of T cell.
His Cell biology study combines topics from a wide range of disciplines, such as Immunotherapy, Adoptive cell transfer and T-cell receptor. His research in T-cell receptor intersects with topics in Antigen and Effector. His work in Immune system tackles topics such as Receptor expression which are related to areas like Cytotoxic T cell and Virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.
Liquan Gao;Ilaria Bellantuono;Annika Elsässer;Stephen B. Marley.
Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity
Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz.
American Journal of Human Genetics (2012)
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
Thomas Stanislawski;Ralf-Holger Voss;Carina Lotz;Elena Sadovnikova.
Nature Immunology (2001)
Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice
Julia Yuen-Shan Tsang;Yakup Tanriver;Shuiping Jiang;Shao-An Xue.
Journal of Clinical Investigation (2008)
Isolation of endothelial cells from murine tissue.
Federica M Marelli-Berg;Emma Peek;Elaine A Lidington;Hans J Stauss.
Journal of Immunological Methods (2000)
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.
Shao-An Xue;Liquan Gao;Daniel Hart;Roopinder Gillmore.
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.
Graham P. Wright;Clare A. Notley;Shao-An Xue;Gavin M. Bendle.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines
Adam J. Gehring;Shao-An Xue;Zi Zong Ho;Denise Teoh.
Journal of Hepatology (2011)
Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.
Jian-Guo Chai;Shao-an Xue;David Coe;Caroline Addey.
Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: Reagents for tumor immunotherapy
Elena Sadovnikova;Hans J. Stauss.
Proceedings of the National Academy of Sciences of the United States of America (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: